Product Launch

Mwyngil Therapeutics starts clinical trials for a novel brain-penetrating drug, aiming to tackle neuroinflammation at its source in MS and Parkinson's.

Unveiled at NADA 2026, AccuTrade's new platform uses AI and risk-scoring to help dealers navigate a complex market and maximize profit on every single VIN.

Brainomix launches its award-winning stroke AI platform with novel Net Water Uptake tech, promising to improve diagnoses, treatment decisions, and patient outcomes.

Cartpanda's new platform integrates checkout, payments, and global sales to streamline operations for high-volume brands, creators, and affiliates.

Tired of high roaming fees? A new program rewards you for using your phone abroad with your existing SIM, turning a travel pain point into a perk.

Feeling stuck planning your next trip? Skyscanner's new data reveals the 10 cheapest destinations for 2026 and a tool to help you beat indecision.

CallRevu launches DylanAI, an AI receptionist embedded in its phone system, promising to eliminate hold times and intelligently route calls for dealers.

Beyond the boardroom, Aloft Surabaya is shaking up the corporate event scene with live cooking, interactive spaces, and a focus on experience.

Chinese startup BanmeGo unveils the T6, a modular delivery robot using advanced AI to make autonomous logistics more accessible and efficient for all.

The 8th ETCIO Annual Conclave shifts focus from theory to deployable playbooks, tackling AI adoption and leadership challenges for India's top CIOs.

KITS Eyecare unveils its AI-powered Pangolin 4 smart glasses, aiming to solve the prescription lens problem that plagues major competitors.

WarmySender's new feature integrates LinkedIn and email, promising to simplify B2B prospecting while making a bold 'zero restrictions' claim.

With a Super Bowl ad, NFL icons like Rob Gronkowski and Novartis are demystifying prostate cancer screening to save lives. Relax, it's a blood test.

Barchart's new browser-based Digital Information Board offers customizable, always-on market data for offices, lobbies, and trading floors globally.

After successful trials in Canada's top oil plays, a new interventionless, degradable completion system promises unlimited stages and major cost savings.

A new app ditches screen time bans for financial rewards, turning parental control into parental investment. But can it work, and is it ethical?

Edtech leader Echo360 targets systemic funding inequities by doubling its grant awards for underserved institutions, fueling AI-powered learning innovation.

Adeptia's new tool promises to slash retirement enrollment times by automating messy data, a move that could unlock revenue and reduce costly errors.

As T+1 deadlines squeeze financial firms, STP Investment Services unveils SmartSettle AI to predict and prevent costly settlement failures.

A German biotech's novel oral drug for herpes is moving to Phase 2 trials, offering new hope against a widespread and often resistant virus.